"False"
Umeå University
printicon
Main menu hidden.

Charlotta Wadsten

Contact

E-mail
charlotta.wadsten@umu.se
Phone

Works at

Affiliation
Affiliated as physician at Department of Diagnostics and Intervention Section: Surgery
Location
5A, Målpunkt H62, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study
British Journal of Surgery, Oxford University Press 2024, Vol. 111, (2)
Rask, Gunilla; Wadsten, Charlotta; Acs, Balazs; et al.
Breast cancer recurrence in relation to mode of detection: implications on personalized surveillance
Breast Cancer Research and Treatment
Sartor, Hanna; Hagberg, Oskar; Hemmingsson, Oskar; et al.
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study
Breast Cancer Research and Treatment, Springer Nature 2024, Vol. 207 : 293-299
Strell, Carina; Smith, Daniel Robert; Valachis, Antonis; et al.
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: a registry-based study
Breast, Vol. 73
Söderberg, Emma; Wärnberg, Fredrik; Wennstig, Anna-Karin; et al.
Management and risk of upgrade of atypical ductal hyperplasia in the breast: a population-based retrospective cohort study
Scandinavian Journal of Surgery, Sage Publications 2024, Vol. 113, (3) : 229-236
Wadsten, Charlotta; Rask, Gunilla
Angiosarcoma in the breast: a population-based cohort from Sweden
British Journal of Surgery, Oxford University Press 2023, Vol. 110, (12) : 1850-1856
Olander, Susanne; Wennstig, Anna-Karin; Garmo, Hans; et al.
Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS)
Acta Oncologica, Taylor & Francis 2023, Vol. 62, (9) : 1045-1051
Wärnberg, Fredrik; Wadsten, Charlotta; Karakatsanis, Andreas; et al.
Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study
Breast Cancer Research and Treatment
Rask, Gunilla; Nazemroaya, Anoosheh; Jansson, Malin; et al.
Data Resource Profile: Breast Cancer Data Base Sweden 2.0 (BCBaSe 2.0)
International Journal of Epidemiology, Oxford University Press 2021, Vol. 50, (6) : 1770-1771f
Wadsten, Charlotta; Wennstig, Anna-Karin; Garmo, Hans; et al.
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study
npj Breast Cancer, Springer Nature 2021, Vol. 7, (1)
Wennstig, Anna-Karin; Wadsten, Charlotta; Garmo, Hans; et al.
A novel biosignature to assess residual risk in ductal carcinoma in situ (DCIS) patients after standard treatment
Journal of Clinical Oncology, American Society of Clinical Oncology 2020, Vol. 38, (15) : 548-548
Bremer, Troy; Shah, Chirag; Patel, Rakesh; et al.
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large populationbased cohort
Breast Cancer Research, London: BioMed Central 2020, Vol. 22, (10)
Wennstig, Anna-Karin; Wadsten, Charlotta; Garmo, Hans; et al.
A biologic signature to predict ipsilateral breast event risk at 10 years for early breast cancer
Cancer Research, American Association for Cancer Research 2019, Vol. 79, (4)
Bremer, T.; Savala, J.; Leesman, G.; et al.
Risk stratification in early stage luminal breast cancer patients treated with and without RT
Journal of Clinical Oncology, Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden. Nashville Breast Ctr, Nashville, TN USA. Univ WI Hosp, Madison, WI USA. PreludeDx, Laguna Hills, CA USA. Uppsala Univ, Reg Oncol Ctr, Uppsala, Sweden.: American Society of Clinical Oncology 2019, Vol. 37, (15) : 568-568
Wadsten, Charlotta; Whitworth, Pat W.; Patel, Rakesh; et al.
Risk of ischemic heart disease after adjuvant radiotherapy for breast cancer
Cancer Research, American Association for Cancer Research 2019, Vol. 79, (4)
Wennstig, Anna-Karin; Wadsten, C.; Garmo, H.; et al.
DCIS of the breast: aspects on treatment and prognosis
Umeå University medical dissertations, 1972
Wadsten, Charlotta
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ
Breast Cancer Research and Treatment, Springer 2018, Vol. 171, (1) : 95-101
Wadsten, Charlotta; Wennstig, A.-K; Garmo, H.; et al.
Risk of death from breast cancer after treatment for ductal carcinoma in situ
British Journal of Surgery, WILEY 2017, Vol. 104, (11) : 1506-1513
Wadsten, Charlotta; Garmo, H.; Fredriksson, I.; et al.
DCIS and the risk of breast cancer death: a case control study
Cancer Research, Vol. 77
Wadsten, Charlotta; Garmo, H.; Fredriksson, I.; et al.
A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years: Two decades of DCIS in Sweden
Acta Oncologica, Vol. 55, (11) : 1338-1343
Wadsten, Charlotta; Heyman, Hanna; Holmqvist, Marit; et al.
Biomarkers in DCIS associated with breast cancer related death
Wadsten, Charlotta; Wennstig, A. K.; Garmo, H.; et al.
View publications in DiVA